natgillin/translations-raw huggingface dataset:
NAME OF THE MEDICINAL PRODUCT AND ROUTE OF ADMINISTRATION Humalog Mix50 100 units/ml KwikPen, suspension for injection 50% insulin lispro and 50% insulin lispro protamine suspension Subcutaneous use 
IME ZDRAVILA IN POT UPORABE Humalog Mix50 100 enot/ml KwikPen suspenzija za injiciranje Suspenzija 50 % insulina lispro in 50 % insulina lispro-protamin Za subkutano uporabo
Humalog Junior KwikPen Parts 
Deli peresnika Humalog Junior KwikPen
PACKAGE LEAFLET: INFORMATION FOR THE USER Humalog Mix50 100 units/ml KwikPen, suspension for injection in a pre-filled pen insulin lispro Each KwikPen delivers 1 - 60 units in steps of 1 units. 
NAVODILO ZA UPORABO Humalog Mix50 100 enot/ml KwikPen suspenzija za injiciranje v napolnjenem injekcijskem peresniku insulin lispro En peresnik KwikPen dostavi od 1 enote do 60 enot v korakih po 1 enoto.
Each pre-filled pen contains 600 units of insulin lispro in 3 ml solution. 
En napolnjen injekcijski peresnik vsebuje 600 enot insulina lispro v 3 ml raztopine.
MARKETING AUTHORISATION NUMBER EU/1/96/007/031 
ŠTEVILKE DOVOLJENJ ZA PROMET Z ZDRAVILOM EU/1/96/007/039
NAME OF THE MEDICINAL PRODUCT Humalog Mix50 100 units/ml KwikPen, suspension for injection in a pre-filled pen 50% insulin lispro and 50% insulin lispro protamine suspension 
Humalog Mix50 100 enot/ml KwikPen suspenzija za injiciranje v napolnjenem injekcijskem peresniku Suspenzija 50 % insulina lispro in 50 % insulina lispro-protamin
Important information about some of the ingredients of Humalog This medicine contains less than 1 mmol sodium (23 mg) per dose, that is to say essentially ‘sodiumfree'. 
Pomembne informacije o nekaterih sestavinah zdravila Humalog To zdravilo vsebuje manj kot 1 mmol (23 mg) natrija na odmerek, kar v bistvu pomeni “brez natrija”.
What you need to know before you use Humalog Mix50 KwikPen 
Kaj morate vedeti, preden boste uporabili zdravilo Humalog Mix50 KwikPen Ne uporabljajte zdravila Humalog Mix50 KwikPen
The pen with the inserted cartridge should not be stored with the needle attached. 
Injekcijskega peresnika z vstavljenim vložkom ne shranjujte s pritrjeno iglo.
NAME OF THE MEDICINAL PRODUCT AND ROUTE OF ADMINISTRATION Humalog 100 units/ml solution for injection in vial Insulin lispro 
IME ZDRAVILA IN POT UPORABE Humalog 100 enot/ml raztopina za injiciranje v viali insulin lispro
NAME OF THE MEDICINAL PRODUCT AND ROUTE OF ADMINISTRATION Humalog Mix25 100 units/ml KwikPen, suspension for injection 25% insulin lispro and 75% insulin lispro protamine suspension Subcutaneous use 
IME ZDRAVILA IN POT UPORABE Humalog Mix25 100 enot/ml KwikPen suspenzija za injiciranje Suspenzija 25 % insulina lispro in 75 % insulina lispro-protamin Za subkutano uporabo
Clinical trials in patients with type 1 and type 2 diabetes have demonstrated reduced postprandial hyperglycaemia with Humalog Mix25 compared to human insulin mixture 30/70. 
Humalog Mix25 v primerjavi z mešanico humanega insulina 30/70 manj postprandialnih hiperglikemij.
Humalog Mix50 100 units/ml, suspension for injection in cartridge insulin lispro 
NAVODILO ZA UPORABO Humalog Mix50 100 enot/ml suspenzija za injiciranje v vložku insulin lispro
MARKETING AUTHORISATION NUMBER EU/1/96/007/021 
ŠTEVILKA(E) DOVOLJENJA(DOVOLJENJ) ZA PROMET EU/1/96/007/021
How to use Humalog Mix25 KwikPen 
Ne uporabljajte zdravila Humalog Mix25 KwikPen
Humalog Mix25 KwikPen is used to treat diabetes. 
Kaj je zdravilo Humalog Mix25 KwikPen in za kaj ga uporabljamo Zdravilo Humalog Mix25 KwikPen uporabljamo za zdravljenje sladkorne bolezni.
MARKETING AUTHORISATION NUMBER EU/1/96/007/035 
ŠTEVILKA(E) DOVOLJENJA(DOVOLJENJ) ZA PROMET EU/1/96/007/035
Package leaflet: Information for the user Humalog 200 units/ml KwikPen, solution for injection in a pre-filled pen insulin lispro Each KwikPen delivers 1 - 60 units in steps of 1 units. 
NAVODILO ZA UPORABO Humalog 200 enot/ml KwikPen raztopina za injiciranje v napolnjenem injekcijskem peresniku insulin lispro En peresnik KwikPen dostavi od 1 enote do 60 enot v korakih po 1 enoto.
• You should normally inject Humalog within 15 minutes of a meal. 
• Normalno si zdravilo Humalog injicirajte v roku 15 minut pred obrokom, po potrebi pa to lahko storite tudi kmalu po obroku.
2 units. 
3 leta.
Important information about some of the ingredients of Humalog Mix25 KwikPen This medicine contains less than 1 mmol sodium (23 mg) per dose, that is to say essentially ‘sodiumfree'. 
Pomembne informacije o nekaterih sestavinah zdravila Humalog Mix25 KwikPen To zdravilo vsebuje manj kot 1 mmol (23 mg) natrija na odmerek, kar v bistvu pomeni “brez natrija”.
The rapid onset and early peak of activity of Humalog itself is observed following the subcutaneous administration of Humalog Mix50. 
Po subkutanem dajanju zdravila Humalog Mix50 je opaziti hiter začetek in zgodnje doseganje največjega delovanja samega zdravila Humalog.
What Humalog Mix25 100 units/ml suspension for injection in vial contains - The active substance is insulin lispro. 
Vsebina pakiranja in dodatne informacije Kaj vsebuje zdravilo Humalog Mix25 100 enot/ml suspenzija za injiciranje v viali - Zdravilna učinkovina je insulin lispro.
Do not mix any other insulin in a Humalog cartridge. 
V vložek zdravila Humalog ne smete primešati kakega drugega insulina.
Before the first use store your Humalog in a refrigerator (2°C - 8°C). 
Pred prvo uporabo shranjujte zdravilo Humalog v hladilniku (2 °C - 8 °C).
MARKETING AUTHORISATION NUMBER EU/1/96/007/034 
ŠTEVILKA(E) DOVOLJENJA(DOVOLJENJ) ZA PROMET EU/1/96/007/034
What Humalog 100 units/ml solution for injection in vial contains - The active substance is insulin lispro. 
Vsebina pakiranja in dodatne informacije Kaj vsebuje zdravilo Humalog 100 enot/ml raztopina za injiciranje v viali - Zdravilna učinkovina je insulin lispro.
MARKETING AUTHORIZATION HOLDER Eli Lilly Nederland B.V., Papendorpseweg 83, 3528 BJ Utrecht, The Netherlands. 
IMETNIK DOVOLJENJA ZA PROMET Eli Lilly Nederland B.V., Papendorpseweg 83, 3528 BJ Utrecht, Nizozemska.
Marketing Authorisation Holder and Manufacturer Humalog Mix25 100 units/ml KwikPen, suspension for injection is made by: 
Zdravilo Humalog Mix25 100 enot/ml KwikPen suspenzijo za injiciranje izdeluje:
Humalog 100 units/ml, solution for injection in cartridge insulin lispro 
Humalog 100 enot/ml raztopina za injiciranje v vložku insulin lispro
Humalog Mix50 100 units/ml KwikPen, suspension for injection is a white, sterile suspension and contains 100 units of insulin lispro in each millilitre (100 units/ml) suspension for injection. 
Zdravilo Humalog Mix50 100 enot/ml KwikPen suspenzija za injiciranje je bela, sterilna suspenzija in vsebuje 100 mednarodnih enot insulina lispro na mililiter (100 enot/ml) suspenzije za injiciranje.
NAME OF THE MEDICINAL PRODUCT AND ROUTE OF ADMINISTRATION Humalog Mix25 100 units/ml suspension for injection in vial 25% insulin lispro and 75% insulin lispro protamine suspension Subcutaneous use 
IME ZDRAVILA IN POT UPORABE Humalog Mix25 100 enot/ml suspenzija za injiciranje v viali Suspenzija 25 % insulina lispro in 75 % insulina lispro-protamin Za subkutano uporabo
Important information about some of the ingredients of Humalog KwikPen This medicine contains less than 1 mmol sodium (23 mg) per dose, that is to say essentially ‘sodiumfree'. 
Pomembne informacije o nekaterih sestavinah zdravila Humalog KwikPen To zdravilo vsebuje manj kot 1 mmol (23 mg) natrija na odmerek, kar v bistvu pomeni “brez natrija”.
Important information about some of the ingredients of Humalog Mix50 This medicine contains less than 1 mmol sodium (23 mg) per dose, that is to say essentially ‘sodiumfree'. 
Pomembne informacije o nekaterih sestavinah zdravila Humalog Mix50 To zdravilo vsebuje manj kot 1 mmol (23 mg) natrija na odmerek, kar v bistvu pomeni “brez natrija”.
Important information about some of the ingredients of Humalog Mix25 This medicine contains less than 1 mmol sodium (23 mg) per dose, that is to say essentially ‘sodiumfree'. 
Pomembne informacije o nekaterih sestavinah zdravila Humalog Mix25 To zdravilo vsebuje manj kot 1 mmol (23 mg) natrija na odmerek, kar v bistvu pomeni “brez natrija”.
MARKETING AUTHORISATION NUMBERS EU/1/96/007/002 
ŠTEVILKA(E) DOVOLJENJA(DOVOLJENJ) ZA PROMET EU/1/96/007/002
MARKETING AUTHORISATION NUMBER EU/1/96/007/036 
ŠTEVILKA(E) DOVOLJENJA(DOVOLJENJ) ZA PROMET EU/1/96/007/036
Humalog Mix25 100 units/ml suspension for injection is a white, sterile suspension and contains 100 units of insulin lispro in each millilitre (100 units/ml) suspension for injection. 
Zdravilo Humalog Mix25 100 enot/ml suspenzija za injiciranje je bela, sterilna suspenzija in vsebuje 100 mednarodnih enot insulina lispro na mililiter (100 enot/ml) suspenzije za injiciranje.
Humalog Mix50 KwikPen is used to treat diabetes. 
Kaj je zdravilo Humalog Mix50 KwikPen in za kaj ga uporabljamo Zdravilo Humalog Mix50 KwikPen uporabljamo za zdravljenje sladkorne bolezni.
NAME OF THE MEDICINAL PRODUCT Humalog Mix50 100 units/ml suspension for injection in cartridge 50% insulin lispro and 50% insulin lispro protamine suspension 
Humalog Mix50 100 enot/ml suspenzija za injiciranje v vložku Suspenzija 50 % insulina lispro in 50 % insulina lispro-protamin
Humalog Mix50 100 units/ml suspension for injection is a white, sterile suspension and contains 100 units of insulin lispro in each millilitre (100 units/ml) suspension for injection. 
Zdravilo Humalog Mix50 100 enot/ml suspenzija za injiciranje je bela, sterilna suspenzija in vsebuje 100 mednarodnih enot insulina lispro na mililiter (100 enot/ml) suspenzije za injiciranje.
What Humalog Mix50 100 units/ml KwikPen, suspension for injection contains - The active substance is insulin lispro. 
Vsebina pakiranja in dodatne informacije Kaj vsebuje zdravilo Humalog Mix50 100 enot/ml KwikPen suspenzija za injiciranje - Zdravilna učinkovina je insulin lispro.
Always use Humalog Mix50 KwikPen exactly as your doctor has told you. 
Pri uporabi zdravila Humalog Mix50 KwikPen natančno upoštevajte zdravnikova navodila.
Humalog 200 units/ml KwikPen solution for injection should not be used intravenously. 
Ne uporabljajte zdravila Humalog 200 enot/ml KwikPen raztopina za injiciranje intravensko.
What Humalog Mix25 100 units/ml KwikPen, suspension for injection contains - The active substance is insulin lispro. 
Vsebina pakiranja in dodatne informacije Kaj vsebuje zdravilo Humalog Mix25 100 enot/ml KwikPen suspenzija za injiciranje - Zdravilna učinkovina je insulin lispro.
NAME OF THE MEDICINAL PRODUCT Humalog Mix25 100 units/ml KwikPen, suspension for injection in a pre-filled pen 25% insulin lispro and 75% insulin lispro protamine suspension 
Humalog Mix25 100 enot/ml KwikPen suspenzija za injiciranje v napolnjenem injekcijskem peresniku Suspenzija 25 % insulina lispro in 75 % insulina lispro-protamin
Always use Humalog Mix25 KwikPen exactly as your doctor has told you. 
Pri uporabi zdravila Humalog Mix25 KwikPen natančno upoštevajte zdravnikova navodila.
MARKETING AUTHORISATION NUMBERS EU/1/96/007/004 
ŠTEVILKA(E) DOVOLJENJA(DOVOLJENJ) ZA PROMET EU/1/96/007/004
PACKAGE LEAFLET: INFORMATION FOR THE USER Humalog 100 units/ml KwikPen, solution for injection in a pre-filled pen insulin lispro Each KwikPen delivers 1 - 60 units in steps of 1 units. 
NAVODILO ZA UPORABO Humalog 100 enot/ml KwikPen raztopina za injiciranje v napolnjenem injekcijskem peresniku insulin lispro En peresnik KwikPen dostavi od 1 enote do 60 enot v korakih po 1 enoto.
NAME OF THE MEDICINAL PRODUCT AND ROUTE OF ADMINISTRATION Humalog Mix50 100 units/ml suspension for injection in cartridge 50% insulin lispro and 50% insulin lispro protamine suspension Subcutaneous use 
IME ZDRAVILA IN POT UPORABE Humalog Mix50 100 enot/ml suspenzija za injiciranje v vložku Suspenzija 50 % insulina lispro in 50 % insulina lispro-protamin Za subkutano uporabo
Always use Humalog exactly as your doctor has told you. 
Vbrizgajte si insulin, kot vam je pokazal zdravnik.
Humalog Mix25 100 units/ KwikPen, suspension for injection is a white, sterile suspension and contains 100 units of insulin lispro in each millilitre (100 units/ml) suspension for injection. 
Zdravilo Humalog Mix25 100 enot/ml KwikPen suspenzija za injiciranje je bela, sterilna suspenzija in vsebuje 100 mednarodnih enot insulina lispro na mililiter (100 enot/ml) suspenzije za injiciranje.
25% of the insulin lispro in Humalog Mix25 KwikPen is dissolved in water and it works more quickly than normal human insulin because the insulin molecule has been changed slightly. 
insulina lispro v zdravilu Humalog Mix25 KwikPen je raztopljenega v vodi in deluje hitreje kakor običajni humani insulin, ker je ta molekula insulina nekoliko spremenjena.
MARKETING AUTHORISATION NUMBERS EU/1/96/007/006 
ŠTEVILKA(E) DOVOLJENJA(DOVOLJENJ) ZA PROMET EU/1/96/007/006
NAME OF THE MEDICINAL PRODUCT AND ROUTE OF ADMINISTRATION Humalog 100 units/ml solution for injection in cartridge Insulin lispro 
IME ZDRAVILA IN POT UPORABE Humalog 100 enot/ml raztopina za injiciranje v vložku insulin lispro
50% of the insulin lispro in Humalog Mix50 KwikPen is dissolved in water and it works more quickly than normal human insulin because the insulin molecule has been changed slightly. 
insulina lispro v zdravilu Humalog Mix50 KwikPen je raztopljenega v vodi in deluje hitreje kakor običajni humani insulin, ker je ta molekula insulina nekoliko spremenjena.
What Humalog looks like and contents of the pack Humalog 100 units/ml, solution for injection is a sterile, clear, colourless, aqueous solution and contains 100 units of insulin lispro in each millilitre (100 units/ml) solution for injection. 
Zdravilo Humalog 100 enot/ml raztopina za injiciranje je sterilna, bistra, brezbarvna vodna raztopina in vsebuje 100 mednarodnih enot insulina lispro na mililiter (100 enot/ml) raztopine za injiciranje.
Marketing Authorisation Holder and Manufacturer Humalog Mix50 100 units/ml suspension for injection in cartridge is made by: 
Imetnik dovoljenja za promet z zdravilom in izdelovalec Zdravilo Humalog Mix50 100 enot/ml suspenzijo za injiciranje v vložku izdeluje:
Step 11: • Pull the Needle out of your skin. 
Korak 12: • Previdno znova namestite zunanje varovalo igle.
• Store the Pen you are currently using at room temperature [up to (30 °C)] and away from dust, 
• Peresnik, ki ga trenutno uporabljate, shranjujte pri sobni temperaturi (do 30 °C) in ga zaščitite pred prahom, hrano in tekočinami, toploto in svetlobo.
NAME OF THE MEDICINAL PRODUCT Humalog Mix25 100 units/ml suspension for injection in vial 25% insulin lispro and 75% insulin lispro protamine suspension 
Humalog Mix25 100 enot/ml suspenzija za injiciranje v viali Suspenzija 25 % insulina lispro in 75 % insulina lispro-protamin
Always check the pack and the cartridge label for the name and type of the insulin when you get it from your pharmacy. 
Kako uporabljati zdravilo Humalog Junior KwikPen Ko vam v lekarni izdajo zdravilo, vedno takoj preglejte oznake na pakiranju in peresniku, da preverite ime in vrsto insulina.
Humalog KwikPen is used to treat diabetes. 
Kaj je zdravilo Humalog KwikPen in za kaj ga uporabljamo Zdravilo Humalog KwikPen uporabljamo za zdravljenje sladkorne bolezni.
Cartridge Humalog cartridges are to be used with a Lilly reusable insulin pen and should not be used with any other reusable pen as the dosing accuracy has not been established with other pens. 
Ne smete jih uporabljati z nobenim drugim injekcijskim peresnikom za večkratno uporabo, saj natančnost odmerjanja za druge injekcijske peresnike ni bila ugotovljena.
Put on a new Needle and prime the Pen. 
Pritrdite novo iglo in pripravite peresnik na injiciranje.
Suspension (cloudy insulin) 
Humalog Mix50 Suspenzija (motni insulin)
What Humalog Mix50 100 units/ml suspension for injection in cartridge looks like and contents of the pack 
Izgled zdravila Humalog Mix50 100 enot/ml suspenzija za injiciranje v vložku in vsebina pakiranja
USER MANUAL Humalog 200 units/ml KwikPen, solution for injection in a pre-filled pen insulin lispro 
Humalog 200 enot/ml KwikPen, raztopina za injiciranje v napolnjenem injekcijskem peresniku insulin lispro
What Humalog Mix50 100 units/ml suspension for injection in cartridge contains - The active substance is insulin lispro. 
Vsebina pakiranja in dodatne informacije Kaj vsebuje zdravilo Humalog Mix50 100 enot/ml suspenzija za injiciranje v vložku - Zdravilna učinkovina je insulin lispro.
NAME OF THE MEDICINAL PRODUCT Humalog Mix25 100 units/ml suspension for injection in cartridge 25% insulin lispro and 75% insulin lispro protamine suspension 
Humalog Mix25 100 enot/ml suspenzija za injiciranje v vložku Suspenzija 25 % insulina lispro in 75 % insulina lispro-protamin
Do NOT use Humalog 200 units/ml KwikPen - if you are allergic to insulin lispro or any of the other ingredients of this medicine (listed in section 6). 
− če ste alergični na insulin lispro ali katerokoli sestavino tega zdravila (navedeno v poglavju 6).
The solution is contained in type I flint glass vials, sealed with butyl or halobutyl stoppers and secured with aluminium seals. 
Viala Raztopina je pakirana v steklene viale iz kremenovega stekla tipa I, zaprte z zamaškom iz butilne ali halobutilne gume in zaščitene z aluminijasto zaporko.
Humalog Mix25 is used to treat diabetes. 
Kaj je zdravilo Humalog Mix25 in za kaj ga uporabljamo Zdravilo Humalog Mix25 uporabljamo za zdravljenje sladkorne bolezni.
NAME OF THE MEDICINAL PRODUCT Humalog 100 units/ml KwikPen, solution for injection in a pre-filled pen Insulin lispro 
Humalog 100 enot/ml KwikPen raztopina za injiciranje v napolnjenem injekcijskem peresniku insulin lispro
It is available as tablets (20 mg, 40 mg and 80 mg). 
Na voljo je v obliki tablet (20, 40 in 80 mg).
It is used in patients who have had problems due to blood clots in the past (such as heart disease, a stroke or artery disease) or who have type 2 diabetes that has damaged an organ (such as the eyes, heart or kidneys). 
Uporablja se pri bolnikih, ki so v preteklosti imeli težave s krvnimi strdki (kot so denimo bolezen srca, kap ali arterijsko obolenje) ali imajo sladkorno bolezen tipa 2, zaradi katere so utrpeli poškodbo organa (npr. oči, srca ali ledvic).
It also allows the heart to pump blood more easily, which can help to reduce the risk of future cardiovascular problems 
Hkrati omogoča, da lahko srce lažje črpa kri po telesu, kar pripomore k zmanjšanju tveganja za pojav srčno-žilnih težav v prihodnosti.
This allows the blood pressure to drop, reducing the risks associated with high blood pressure, such as having a heart attack or stroke. 
Posledica tega je znižanje krvnega tlaka, zaradi česar se zmanjšajo tveganja, povezana z visokim krvnim tlakom, kot sta srčni napad ali kap.
pressure is not reached, the dose can be increased to 80 mg, or another medicine for hypertension can be added, such as hydrochlorothiazide. 
želena vrednost krvnega tlaka ni dosežena, se lahko odmerek poveča na 80 mg ali pa se doda drugo zdravilo za zdravljenje povišanega krvnega tlaka, kot je denimo hidroklorotiazid.
For more information about treatment with Telmisartan Teva Pharma, read the package leaflet (also part of the EPAR) or contact your doctor or pharmacist. 
Za več informacij o zdravljenju z zdravilom Telmisartan Teva Pharma preberite navodilo za uporabo (ki je prav tako del EPAR) ali se posvetujte z zdravnikom ali farmacevtom.
For the treatment of essential hypertension, the usual recommended dose of Telmisartan Teva Pharma is 40 mg once a day, but some patients may benefit from using a 20-mg dose. 
Za zdravljenje esencialne hipertenzije znaša običajni priporočeni odmerek zdravila Telmisartan Teva Pharma 40 mg enkrat dnevno, vendar za nekatere bolnike zadostuje že 20-miligramski odmerek.
Telmisartan Teva Pharma is used to treat essential hypertension (high blood pressure) in adults. 
Zdravilo Telmisartan Teva Pharma se uporablja za zdravljenje esencialne hipertenzije (visokega krvnega tlaka) pri odraslih.
Telmisartan Teva Pharma is also used to prevent cardiovascular problems (problems with the heart and blood vessels) such as heart attacks or strokes. 
Zdravilo Telmisartan Teva Pharma se uporablja tudi za preprečevanje srčno-žilnih težav (težav s srcem in ožiljem), kot sta srčni napad ali kap.
This means that Telmisartan Teva Pharma is similar to a ‘reference medicine' already authorised in the European Union (EU) called Micardis. 
To pomeni, da je podobno „referenčnemu zdravilu“, ki je že odobreno v Evropski uniji (EU), in sicer zdravilu Micardis.
The active substance in Telmisartan Teva Pharma, telmisartan, is an ‘angiotensin II receptor antagonist', which means that it blocks the action of a hormone in the body called angiotensin II. 
Zdravilna učinkovina v zdravilu Telmisartan Teva Pharma, telmisartan, je „antagonist receptorjev angiotenzina II“, kar pomeni, da v telesu zavira delovanje hormona, imenovanega angiotenzin II.
Because Telmisartan Teva Pharma is a generic medicine and is bioequivalent to the reference medicine, its benefits and risks are taken as being the same as the reference medicine's. 
Ker je zdravilo Telmisartan Teva Pharma generično zdravilo in je biološko enakovredno referenčnemu zdravilu, so koristi in tveganja enaki kot pri referenčnem zdravilu.
The doctor should monitor the patient's blood pressure closely when starting Telmisartan Teva Pharma, and may decide to adjust the patient's blood pressure-lowering medication. 
Zdravnik mora ob začetku zdravljenja z zdravilom Telmisartan Teva Pharma skrbno spremljati bolnikov krvni tlak in se po potrebi odločiti za prilagoditev bolnikovega odmerka zdravila za zniževanje krvnega tlaka.
This is a summary of the European Public Assessment Report (EPAR) for Telmisartan Teva Pharma. 
To je povzetek evropskega javnega poročila o oceni zdravila (EPAR) za zdravilo Telmisartan Teva Pharma.
The CHMP concluded that, in accordance with EU requirements, Telmisartan Teva Pharma has been shown to have comparable quality and to be bioequivalent to Micardis. 
CHMP je zaključil, da je bilo v skladu z zahtevami EU dokazano, da ima zdravilo Telmisartan Teva Pharma primerljivo raven kakovosti kot zdravilo Micardis ter da mu je biološko enakovredno.
The European Commission granted a marketing authorisation valid throughout the EU for Telmisartan Teva Pharma on 3 October 2011. 
Evropska komisija je dovoljenje za promet z zdravilom Telmisartan Teva Pharma, veljavno po vsej Evropski uniji, izdala 3. oktobra 2011.
Telmisartan Teva Pharma is a ‘generic medicine'. 
Telmisartan Teva Pharma je „generično zdravilo“.
Because Telmisartan Teva Pharma is a generic medicine, studies in people have been limited to tests to determine that it is bioequivalent to the reference medicine, Micardis. 
Ker je zdravilo Telmisartan Teva Pharma generično zdravilo, so bile študije omejene na preskuse pri ljudeh za ugotavljanje, ali je biološko enakovredno referenčnemu zdravilu Micardis.
It explains how the Committee for Medicinal Products for Human Use (CHMP) assessed the medicine to reach its opinion in favour of granting a marketing authorisation and its recommendations on the conditions of use for Telmisartan Teva Pharma. 
Pojasnjuje, kako je Odbor za zdravila za uporabo v humani medicini (CHMP) ocenil zdravilo Telmisartan Teva Pharma, na podlagi česar je oblikoval mnenje za izdajo dovoljenja za promet z njim in priporočila glede pogojev njegove uporabe.
Other information about Telmisartan Teva Pharma: 
Druge informacije o zdravilu Telmisartan Teva Pharma:
Telmisartan Teva Pharma is a medicine that contains the active substance telmisartan. 
Telmisartan Teva Pharma je zdravilo, ki vsebuje zdravilno učinkovino telmisartan.
What are the benefit and risk of Telmisartan Teva Pharma? 
Kakšne so koristi in tveganja, povezani z zdravilom Telmisartan Teva Pharma?
The Committee recommended that Telmisartan Teva Pharma be given marketing authorisation. 
Odbor je priporočil, da se za zdravilo Telmisartan Teva Pharma odobri dovoljenje za promet.
Patients with mild or moderately reduced liver function should not receive doses higher than 40 mg a day 
Bolniki s hudi okvaro delovanja ledvic morajo prejemati nižji začetni 20-miligramski odmerek enkrat na dan. Bolniki z blago do zmerno okvaro delovanja ledvic ne smejo prejemati odmerkov, višjih od 40 mg na dan.
Why has Telmisartan Teva Pharma been approved? 
Zakaj je bilo zdravilo Telmisartan Teva Pharma odobreno?